Some of these studies evaluated GBCA use for durations >1 year and showed that gadolinium is retained in organs such as the brain, bones, and skin. After evaluating the risk of brain deposits with ...
The U.S. Food and Drug Administration is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as ...
Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function. The Food and Drug Administration (FDA) announced a new class warning and safety ...
The US Food and Drug Administration (FDA) will require a new class-wide warning for all gadolinium-based contrast agents (GBCAs) regarding gadolinium remaining in the body for months or years after ...
Chuck and Gena Norris are suing manufacturers and distributors of a contrast agent used in Magnetic Resonance Imaging (MRI) for ill effects on Gena’s health. Here is the background and some of the ...
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast agents during MRI scans. Emerging research suggests gadolinium-based contrast ...
SAN FRANCISCO--(BUSINESS WIRE)--Chuck and Gena Norris announced today that they have filed a lawsuit against eleven drug companies, including McKesson and Bracco, that they claim are responsible for ...
SAN FRANCISCO-- Action star Chuck Norris took on medical device manufacturers in a lawsuit filed in California on Wednesday alleging a chemical used in MRI imaging scans poisoned his wife. Gadolinium ...
The Medical Imaging Drugs Advisory Committee (MIDAC) of the US Food and Drug Administration (FDA) voted 13 to 1 on Friday, with 1 abstention, for recommending adding a warning to labels about ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. On Thursday, a law firm announced it was representing Chuck Norris in a ...
On the surface, being on active surveillance (AS) for prostate cancer appears to be a care-free walk in the park as one avoids radical prostatectomy, radiation, and other therapies with serious side ...